Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)

BACKGROUND: This was the first large-scale prospective observational Japanese study evaluating the safety and efficacy of bevacizumab combined with paclitaxel and carboplatin for newly diagnosed advanced ovarian cancer. METHODS: Patients were prospectively enrolled in the primary analysis cohort if...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Clin Oncol
Auteurs principaux: Komiyama, Shinichi, Kato, Kazuyoshi, Inokuchi, Yuki, Takano, Hirokuni, Matsumoto, Takashi, Hongo, Atsushi, Asai-Sato, Mikiko, Arakawa, Atsushi, Kamiura, Shoji, Tabata, Tsutomu, Takeshima, Nobuhiro, Sugiyama, Toru
Format: Artigo
Langue:Inglês
Publié: Springer Singapore 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6326987/
https://ncbi.nlm.nih.gov/pubmed/30030657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-018-1319-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires